bioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 14,200 shares, a drop of 47.6% from the December 31st total of 27,100 shares. Approximately 0.4% of the company’s shares are short sold. […]
bioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Free Report) was the recipient of a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 14,200 shares, a decrease of 47.6% from the December 31st total of 27,100 shares. Based on an average daily volume of 14,400 shares, […]
bioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and OneMedNet (NASDAQ:ONMD – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk. Volatility & Risk bioAffinity Technologies has a beta […]
bioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and Guardant Health (NASDAQ:GH – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk. Institutional & Insider Ownership 1.1% of bioAffinity Technologies […]
bioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and Starpharma (OTCMKTS:SPHRY – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Profitability This table compares bioAffinity Technologies and Starpharma’s […]